Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IKC in Stage IV NSCLC
NCT03499834Phase 2Completed
- Sponsor
- Ivy Life Sciences
- Start
- Dec 2017
- Primary completion
- Feb 2020
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Immune Killer Cell in non-small cell lung cancer (NSCLC), sponsored by Ivy Life Sciences. Started Dec 2017; status: completed.
02
Drugs
Immune Killer Cell
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03499834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499834.